Physician profile
Peter S Herman
NPI 1669464285
$2,844.79
in general payments reported to CMS, 2019-2025
22 companies · $315 in 2025
The $315 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $460 · 2020: $232 · 2021: $172 · 2022: $650 · 2023: $562 · 2024: $454 · 2025: $315.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,331.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,330.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $1,265.82 | 2021-2025 | Opzelura |
| Pfizer INC. | $332.23 | 2019-2023 | |
| Abbvie INC. | $184.67 | 2023-2025 | |
| Journey Medical Corporation | $175.32 | 2022-2023 | |
| Melinta Therapeutics, LLC | $128.27 | 2019 | |
| Sun Pharmaceutical Industries INC. | $111.45 | 2020-2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $99.08 | 2019-2021 | |
| Alexion Pharmaceuticals, INC. | $93.93 | 2024 | Koselugo |
| Regeneron Healthcare Solutions, INC. | $61.59 | 2019-2025 | Libtayo |
| Vyne Pharmaceuticals INC. | $56.76 | 2020 | |
| Janssen Biotech, INC. | $50.96 | 2021-2023 | Remicade, Stelara, Simponi |
| Dermira, INC. | $44.14 | 2020-2021 | |
| Tactile Systems Technology INC | $42.47 | 2019-2020 | |
| Almirall LLC | $39.58 | 2020-2022 | |
| Organon LLC | $39.42 | 2025 | Vtama |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Prugen, INC. Pharmaceuticals | $27.06 | 2019 | |
| Arcutis Biotherapeutics, INC. | $22.11 | 2024 | Zoryve |
| Celgene Corporation | $16.26 | 2019 | |
| Galderma Laboratories, L.P. | $15.19 | 2019 | |
| Dermavant Sciences, INC. | $14.00 | 2022 | |
| Aclaris Therapeutics, INC. | $12.30 | 2019 | |
| Merck Sharp & Dohme LLC | $12.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Herman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.